Cancer Research Meeting Calendar Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, D. R.
Right arrow Articles by Cho, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, D. R.
Right arrow Articles by Cho, K. R.
[Cancer Research 62, 4722-4729, August 15, 2002]
© 2002 American Association for Cancer Research

Molecular Biology and Genetics

Gene Expression in Ovarian Cancer Reflects Both Morphology and Biological Behavior, Distinguishing Clear Cell from Other Poor-Prognosis Ovarian Carcinomas1

Donald R. Schwartz, Sharon L. R. Kardia, Kerby A. Shedden, Rork Kuick, George Michailidis, Jeremy M. G. Taylor, David E. Misek, Rong Wu, Yali Zhai, Danielle M. Darrah, Heather Reed, Lora H. Ellenson, Thomas J. Giordano, Eric R. Fearon, Samir M. Hanash and Kathleen R. Cho2

Departments of Pathology [D. R. S., R. W., Y. Z., D. M. D., H. R., T. J. G., E. R. F., K. R. C.], Internal Medicine [K. R. C., E. R. F.], Pediatrics and Communicable Diseases [R. K., D. E. M., S. M. H.], Biostatistics [J. M. G. T.], Epidemiology [S. L. R. K.], and Statistics [K. A. S., G. M.], The University of Michigan, Ann Arbor, Michigan. 48109, and Department of Pathology, Weill Medical College of Cornell University, New York, New York, 10021 [L. H. E.]

Biologically and clinically meaningful tumor classification schemes have long been sought. Some malignant epithelial neoplasms, such as those in the thyroid and endometrium, exhibit more than one pattern of differentiation, each associated with distinctive clinical features and treatments. In other tissues, all carcinomas, regardless of morphological type, are treated as though they represent a single disease. To better understand the biological and clinical features seen in the four major histological types of ovarian carcinoma (OvCa), we analyzed gene expression in 113 ovarian epithelial tumors using oligonucleotide microarrays. Global views of the variation in gene expression were obtained using PCA. These analyses show that mucinous and clear cell OvCas can be readily distinguished from serous OvCas based on their gene expression profiles, regardless of tumor stage and grade. In contrast, endometrioid adenocarcinomas show significant overlap with other histological types. Although high-stage/grade tumors are generally separable from low-stage/grade tumors, clear cell OvCa has a molecular signature that distinguishes it from other poor-prognosis OvCas. Indeed, 73 genes, expressed 2- to 29-fold higher in clear cell OvCas compared with each of the other OvCa types, were identified. Collectively, the data indicate that gene expression patterns in ovarian adenocarcinomas reflect both morphological features and biological behavior. Moreover, these studies provide a foundation for the development of new type-specific diagnostic strategies and treatments for ovarian cancer.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
A. Berchuck, E. S. Iversen, J. Luo, J. P. Clarke, H. Horne, D. A. Levine, J. Boyd, M. A. Alonso, A. A. Secord, M. Q. Bernardini, et al.
Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
Clin. Cancer Res., April 1, 2009; 15(7): 2448 - 2455.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. W. Tothill, A. V. Tinker, J. George, R. Brown, S. B. Fox, S. Lade, D. S. Johnson, M. K. Trivett, D. Etemadmoghadam, B. Locandro, et al.
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Clin. Cancer Res., August 15, 2008; 14(16): 5198 - 5208.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.-G. Liu, H. Alder, et al.
MicroRNA Signatures in Human Ovarian Cancer
Cancer Res., September 15, 2007; 67(18): 8699 - 8707.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. R. Evelyn, S. M. Wade, Q. Wang, M. Wu, J. A. Iniguez-Lluhi, S. D. Merajver, and R. R. Neubig
CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling
Mol. Cancer Ther., August 1, 2007; 6(8): 2249 - 2260.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. S. N. Fehrmann, X.-y. Li, A. G. J. van der Zee, S. de Jong, G. J. te Meerman, E. G. E. de Vries, and A. P. G. Crijns
Profiling Studies in Ovarian Cancer: A Review
Oncologist, August 1, 2007; 12(8): 960 - 966.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S. M El-Naggar, M. T Malik, A. Martin, J. P Moore, M. Proctor, T. Hamid, and S. S Kakar
Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice
J. Endocrinol., July 1, 2007; 194(1): 179 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
D. R. Schwartz, K. Moin, B. Yao, L. M. Matrisian, L. M. Coussens, T. H. Bugge, B. Fingleton, H. B. Acuff, M. Sinnamon, H. Nassar, et al.
Hu/Mu ProtIn Oligonucleotide Microarray: Dual-Species Array for Profiling Protease and Protease Inhibitor Gene Expression in Tumors and Their Microenvironment
Mol. Cancer Res., May 1, 2007; 5(5): 443 - 454.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
D. S P Tan and S. Kaye
Ovarian clear cell adenocarcinoma: a continuing enigma
J. Clin. Pathol., April 1, 2007; 60(4): 355 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Itamochi, J. Kigawa, Y. Kanamori, T. Oishi, C. Bartholomeusz, R. Nahta, F. J. Esteva, N. Sneige, N. Terakawa, and N. T. Ueno
Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy
Mol. Cancer Ther., January 1, 2007; 6(1): 227 - 235.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A Bamias, Z Yu, P. Weinberger, S Markakis, D Kowalski, R. Camp, D. Rimm, M. Dimopoulos, and A Psyrri
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with {beta}-catenin levels and outcome in patients with epithelial ovarian cancer
Ann. Onc., December 1, 2006; 17(12): 1797 - 1802.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Denkert, J. Budczies, T. Kind, W. Weichert, P. Tablack, J. Sehouli, S. Niesporek, D. Konsgen, M. Dietel, and O. Fiehn
Mass Spectrometry-Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors.
Cancer Res., November 15, 2006; 66(22): 10795 - 10804.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Castellano, J. F. Reid, P. Alberti, M. L. Carcangiu, A. Tomassetti, and S. Canevari
New Potential Ligand-Receptor Signaling Loops in Ovarian Cancer Identified in Multiple Gene Expression Studies
Cancer Res., November 15, 2006; 66(22): 10709 - 10719.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
P. L. Lorenzi, W. C. Reinhold, M. Rudelius, M. Gunsior, U. Shankavaram, K. J. Bussey, U. Scherf, G. S. Eichler, S. E. Martin, K. Chin, et al.
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells
Mol. Cancer Ther., November 1, 2006; 5(11): 2613 - 2623.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. DiFeo, G. Narla, J. Hirshfeld, O. Camacho-Vanegas, J. Narla, S. L. Rose, T. Kalir, S. Yao, A. Levine, M. J. Birrer, et al.
Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination.
Clin. Cancer Res., June 15, 2006; 12(12): 3730 - 3739.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Zhang, J. Huang, N. Yang, S. Liang, A. Barchetti, A. Giannakakis, M. G. Cadungog, A. O'Brien-Jenkins, M. Massobrio, K. F. Roby, et al.
Integrative Genomic Analysis of Protein Kinase C (PKC) Family Identifies PKC{iota} as a Biomarker and Potential Oncogene in Ovarian Carcinoma.
Cancer Res., May 1, 2006; 66(9): 4627 - 4635.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. D. Hendrix, R. Wu, R. Kuick, D. R. Schwartz, E. R. Fearon, and K. R. Cho
Fibroblast Growth Factor 9 Has Oncogenic Activity and Is a Downstream Target of Wnt Signaling in Ovarian Endometrioid Adenocarcinomas
Cancer Res., February 1, 2006; 66(3): 1354 - 1362.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Y. Wang, R. Wu, K. R. Cho, K. A. Shedden, T. J. Barder, and D. M. Lubman
Classification of Cancer Cell Lines Using an Automated Two-dimensional Liquid Mapping Method with Hierarchical Clustering Techniques
Mol. Cell. Proteomics, January 1, 2006; 5(1): 43 - 52.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Avril, S. Sassen, B. Schmalfeldt, J. Naehrig, S. Rutke, W. A. Weber, M. Werner, H. Graeff, M. Schwaiger, and W. Kuhn
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7445 - 7453.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Tsuda, Y. M. Ito, Y. Ohashi, K.-K. Wong, Y. Hashiguchi, W. R. Welch, R. S. Berkowitz, M. J. Birrer, and S. C. Mok
Identification of Overexpression and Amplification of ABCF2 in Clear Cell Ovarian Adenocarcinomas by cDNA Microarray Analyses
Clin. Cancer Res., October 1, 2005; 11(19): 6880 - 6888.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. K. Zorn, T. Bonome, L. Gangi, G. V.R. Chandramouli, C. S. Awtrey, G. J. Gardner, J. C. Barrett, J. Boyd, and M. J. Birrer
Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer
Clin. Cancer Res., September 15, 2005; 11(18): 6422 - 6430.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. T. Marquez, K. A. Baggerly, A. P. Patterson, J. Liu, R. Broaddus, M. Frumovitz, E. N. Atkinson, D. I. Smith, L. Hartmann, D. Fishman, et al.
Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon
Clin. Cancer Res., September 1, 2005; 11(17): 6116 - 6126.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Eder, X. Sui, D. G. Rosen, L. K Nolden, K. W. Cheng, J. P. Lahad, M. Kango-Singh, K. H. Lu, C. L. Warneke, E. N. Atkinson, et al.
Atypical PKC{iota} contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer
PNAS, August 30, 2005; 102(35): 12519 - 12524.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Mor, I. Visintin, Y. Lai, H. Zhao, P. Schwartz, T. Rutherford, L. Yue, P. Bray-Ward, and D. C. Ward
Serum protein markers for early detection of ovarian cancer
PNAS, May 24, 2005; 102(21): 7677 - 7682.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. D. Santin, S. Cane, S. Bellone, M. Palmieri, E. R. Siegel, M. Thomas, J. J. Roman, A. Burnett, M. J. Cannon, and S. Pecorelli
Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens Enterotoxin
Cancer Res., May 15, 2005; 65(10): 4334 - 4342.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Berchuck, E. S. Iversen, J. M. Lancaster, J. Pittman, J. Luo, P. Lee, S. Murphy, H. K. Dressman, P. G. Febbo, M. West, et al.
Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers
Clin. Cancer Res., May 15, 2005; 11(10): 3686 - 3696.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. A. Shedden, M. P. Kshirsagar, D. R. Schwartz, R. Wu, H. Yu, D. E. Misek, S. Hanash, H. Katabuchi, L. H. Ellenson, E. R. Fearon, et al.
Histologic Type, Organ of Origin, and Wnt Pathway Status: Effect on Gene Expression in Ovarian and Uterine Carcinomas
Clin. Cancer Res., March 15, 2005; 11(6): 2123 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. C. Hartmann, K. H. Lu, G. P. Linette, W. A. Cliby, K. R. Kalli, D. Gershenson, R. C. Bast, J. Stec, N. Iartchouk, D. I. Smith, et al.
Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
Clin. Cancer Res., March 15, 2005; 11(6): 2149 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Morrison, W. Farrar, J. Kneile, N. Williams, Y. Liu-Stratton, A. Bakaletz, M. A. Aldred, and C. Eng
Molecular Classification of Parathyroid Neoplasia by Gene Expression Profiling
Am. J. Pathol., August 1, 2004; 165(2): 565 - 576.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
PNAS, June 22, 2004; 101(25): 9309 - 9314.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. H. Lu, A. P. Patterson, L. Wang, R. T. Marquez, E. N. Atkinson, K. A. Baggerly, L. R. Ramoth, D. G. Rosen, J. Liu, I. Hellstrom, et al.
Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis
Clin. Cancer Res., May 15, 2004; 10(10): 3291 - 3300.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Terasawa, S. Sagae, M. Toyota, K. Tsukada, K. Ogi, A. Satoh, H. Mita, K. Imai, T. Tokino, and R. Kudo
Epigenetic Inactivation of TMS1/ASC in Ovarian Cancer
Clin. Cancer Res., March 15, 2004; 10(6): 2000 - 2006.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Liu, G. Yang, J. A. Thompson-Lanza, A. Glassman, K. Hayes, A. Patterson, R. T. Marquez, N. Auersperg, Y. Yu, W. C. Hahn, et al.
A Genetically Defined Model for Human Ovarian Cancer
Cancer Res., March 1, 2004; 64(5): 1655 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
C. E. Schmalbach, D. B. Chepeha, T. J. Giordano, M. A. Rubin, T. N. Teknos, C. R. Bradford, G. T. Wolf, R. Kuick, D. E. Misek, D. K. Trask, et al.
Molecular Profiling and the Identification of Genes Associated With Metastatic Oral Cavity/Pharynx Squamous Cell Carcinoma
Arch Otolaryngol Head Neck Surg, March 1, 2004; 130(3): 295 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Li, M. Cuilleron, A. Gentil-Perret, M. Cottier, K. Passebosc-Faure, C. Lambert, C. Genin, and J. Tostain
Rapid and Sensitive Detection of Messenger RNA Expression for Molecular Differential Diagnosis of Renal Cell Carcinoma
Clin. Cancer Res., December 15, 2003; 9(17): 6441 - 6446.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Tsuchiya, M. Sakamoto, J. Yasuda, M. Chuma, T. Ohta, M. Ohki, T. Yasugi, Y. Taketani, and S. Hirohashi
Expression Profiling in Ovarian Clear Cell Carcinoma: Identification of Hepatocyte Nuclear Factor-1{beta} as a Molecular Marker and a Possible Molecular Target for Therapy of Ovarian Clear Cell Carcinoma
Am. J. Pathol., December 1, 2003; 163(6): 2503 - 2512.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
K. A. Shedden, J. M. G. Taylor, T. J. Giordano, R. Kuick, D. E. Misek, G. Rennert, D. R. Schwartz, S. B. Gruber, C. Logsdon, D. Simeone, et al.
Accurate Molecular Classification of Human Cancers Based on Gene Expression Using a Simple Classifier with a Pathological Tree-Based Framework
Am. J. Pathol., November 1, 2003; 163(5): 1985 - 1995.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Reed, J. J. Yu, A. Davies, J. Gannon, and S. L. Armentrout
Clear Cell Tumors Have Higher mRNA Levels of ERCC1 and XPB Than Other Histological Types of Epithelial Ovarian Cancer
Clin. Cancer Res., November 1, 2003; 9(14): 5299 - 5305.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. E. Schaner, D. T. Ross, G. Ciaravino, T. Sorlie, O. Troyanskaya, M. Diehn, Y. C. Wang, G. E. Duran, T. L. Sikic, S. Caldeira, et al.
Gene Expression Patterns in Ovarian Carcinomas
Mol. Biol. Cell, November 1, 2003; 14(11): 4376 - 4386.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. K. Zorn, A. A. Jazaeri, C. S. Awtrey, G. J. Gardner, S. C. Mok, J. Boyd, and M. J. Birrer
Choice of Normal Ovarian Control Influences Determination of Differentially Expressed Genes in Ovarian Cancer Expression Profiling Studies
Clin. Cancer Res., October 15, 2003; 9(13): 4811 - 4818.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. R. Schwartz, R. Wu, S. L. R. Kardia, A. M. Levin, C.-C. Huang, K. A. Shedden, R. Kuick, D. E. Misek, S. M. Hanash, J. M. G. Taylor, et al.
Novel Candidate Targets of {beta}-Catenin/T-cell Factor Signaling Identified by Gene Expression Profiling of Ovarian Endometrioid Adenocarcinomas
Cancer Res., June 1, 2003; 63(11): 2913 - 2922.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Hirasawa, F. Saito-Ohara, J. Inoue, D. Aoki, N. Susumu, T. Yokoyama, S. Nozawa, J. Inazawa, and I. Imoto
Association of 17q21-q24 Gain in Ovarian Clear Cell Adenocarcinomas with Poor Prognosis and Identification of PPM1D and APPBP2 as Likely Amplification Targets
Clin. Cancer Res., June 1, 2003; 9(6): 1995 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Wu, L. Lin, D. G. Beer, L. H. Ellenson, B. J. Lamb, J.-M. Rouillard, R. Kuick, S. Hanash, D. R. Schwartz, E. R. Fearon, et al.
Amplification and Overexpression of the L-MYC Proto-Oncogene in Ovarian Carcinomas
Am. J. Pathol., May 1, 2003; 162(5): 1603 - 1610.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. Singer, R. Oldt III, Y. Cohen, B. G. Wang, D. Sidransky, R. J. Kurman, and I.-M. Shih
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
J Natl Cancer Inst, March 19, 2003; 95(6): 484 - 486.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.